Unexpected detection of a meningioma on 18F-Fluorocholine PET/CT in a prostate cancer patient

Authors

  • Yassir Benameur Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat; Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Morocco
  • Ikram Zahfir Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat; Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Morocco
  • Meryem Aboussabr Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat; Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Morocco
  • Salah Nabih Oueriagli Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat; Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Morocco
  • Jaafar El Bakkali Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat; Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Morocco
  • Omar Ait Sahel Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat; Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Morocco
  • Abderrahim Doudouh Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat; Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Morocco

DOI:

https://doi.org/10.25305/unj.334674

Keywords:

prostate cancer, meningioma, 18F-Fluorocholine, PET-CT

Abstract

A 77-year-old man with a prior diagnosis of prostate adenocarcinoma, previously treated with radiotherapy and hormone therapy, presented with rising PSA levels suggestive of biochemical recurrence. While no evidence of metastatic prostate disease was detected, the PET/CT (positron emission tomography–computed tomography) scan incidentally revealed an area of abnormal radiotracer uptake in the left temporal lobe of the brain, unrelated to the patient’s known malignancy. The imaging characteristics raised the suspicion of a meningioma. A subsequent brain MRI confirmed the presence of an extra-axial lesion consistent with a meningioma. This unexpected finding highlights the additional diagnostic value of 18F-fluorocholine PET/CT beyond its primary role in prostate cancer imaging, particularly in detecting clinically significant incidental intracranial lesions. This case underscores the importance of careful and systematic interpretation of imaging studies during oncologic evaluations, even in regions outside the primary area of concern.

References

1. Vali R, Loidl W, Pirich C, Langesteger W, Beheshti M. Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine. Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):96-108. [PubMed] [PubMed Central]

2. Henriksen G, Herz M, Hauser A, Schwaiger M, Wester HJ. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC). Nucl Med Biol. 2004 Oct;31(7):851-8. [CrossRef] [PubMed]

3. Evangelista L, Zattoni F, Guttilla A, Saladini G, Zattoni F, Colletti PM, Rubello D. Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. Clin Nucl Med. 2013 May;38(5):305-14. [CrossRef] [PubMed]

4. Galldiks N, Albert NL, Sommerauer M, Grosu AL, Ganswindt U, Law I, Preusser M, Le Rhun E, Vogelbaum MA, Zadeh G, Dhermain F, Weller M, Langen KJ, Tonn JC. PET imaging in patients with meningioma-report of the RANO/PET Group. Neuro Oncol. 2017 Nov 29;19(12):1576-1587. [CrossRef] [PubMed] [PubMed Central]

5. Beheshti M, Imamovic L, Broinger G, Vali R, Waldenberger P, Stoiber F, Nader M, Gruy B, Janetschek G, Langsteger W. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. Radiology. 2010 Mar;254(3):925-33. [CrossRef] [PubMed]

6. Buetow MP, Buetow PC, Smirniotopoulos JG. Typical, atypical, and misleading features in meningioma. Radiographics. 1991 Nov;11(6):1087-106. [CrossRef] [PubMed]

7. Einhellig HC, Siebert E, Bauknecht HC, Tietze A, Graef J, Furth C, Schulze D, Miszczuk M, Bohner G, Schatka I, Makowski MR. Comparison of diagnostic value of 68 Ga-DOTATOC PET/MRI and standalone MRI for the detection of intracranial meningiomas. Sci Rep. 2021 Apr 27;11(1):9064. [CrossRef] [PubMed] [PubMed Central]

8. Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021 Nov 2;23(11):1821-1834. [CrossRef] [PubMed] [PubMed Central]

Downloads

Published

2025-12-29

How to Cite

Benameur, Y., Zahfir, I., Aboussabr, M., Oueriagli, S. N., El Bakkali, J., Ait Sahel, O., & Doudouh, A. (2025). Unexpected detection of a meningioma on 18F-Fluorocholine PET/CT in a prostate cancer patient. Ukrainian Neurosurgical Journal, 31(4), 74–76. https://doi.org/10.25305/unj.334674

Issue

Section

Case Report